Mouhamad Khouja

During the annual EHA annual conference in Stockholm June 11-14, the Czernecki Donnelly Prize 2026 has been awarded to Mouhamad Khouja, University of Schleswig-Holstein for his work.

 

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

 

Download Manuscript

 

 

David Lewis

The Special Clinical Award was presented to David Lewis from the University of Plymouth for his work.

 

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

 

Download Article